Healthcare / Health Information ServicesKOSDAQ
$2590.00
-240.00 (-8.48%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 24%
FCF escenarios
weak_data · normalized FCF $-7.2B · quality 73.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
23/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$63.2B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-37.7%
↓Gross Margin
64.1%
↑Debt/Equity
0.24
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+32.9%
FCF CAGR
—
FCF margin
-96.9%
FCF / Net income
0.67x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $7.47B · net income $-10.75B · FCF $-7.24B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.47B | $7.47B | $10.85B | $1.93B | $3.18B |
| Net Income | $-10.75B | $-10.75B | $-9.08B | $-6.74B | $-5.33B |
| EBITDA | $-9.52B | $-9.52B | $-8.05B | $-5.98B | $-4.61B |
| EPS | -472.00 | -472.00 | -383.07 | -158.85 | -245.39 |
| Gross Margin | 64.1% | 64.1% | 9.5% | 41.9% | 48.7% |
| Operating Margin | -141.3% | -141.3% | -93.1% | -348.0% | -193.6% |
| Net Margin | -143.8% | -143.8% | -83.7% | -348.5% | -167.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.24 | 0.24 | 0.39 | 0.01 | 0.06 |
| Current Ratio | 8.06 | 8.06 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-7.24B | $-7.24B | $-23.30B | $-5.59B | $-4.23B |
| Returns | |||||
| ROE | -37.7% | -37.7% | -47.7% | -24.8% | -53.5% |
| Valuation | |||||
| P/B | 2.07 | 2.07 | 7.28 | 35.11 | 11.32 |
| Growth & Yield | |||||
| Revenue Growth | -31.1% | -31.1% | 461.1% | -39.2% | — |
| EPS Growth | -23.2% | -23.2% | -141.1% | 35.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-60.3%
Start / end P/E
n/dx → n/dx
EPS bridge
-383.07 → -472.00
Residual
-60.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.